Chemence

Chemence Launches KURA-LOW™ Adhesive Technology Chemistry Platform Driving Paradigm Shift for Consumer Electronic Device Assembly Processes

Retrieved on: 
Monday, September 18, 2023

Performance Materials research scientists are committed to solving next generation bonding challenges for Electronics Device Assembly .

Key Points: 
  • Performance Materials research scientists are committed to solving next generation bonding challenges for Electronics Device Assembly .
  • This corporate commitment to being a solution provider for the industry has led to the development of a new chemistry platform, KURA-LOW™ available in some KRYLEX adhesive formulations manufactured by Chemence, Inc.
  • View the full release here: https://www.businesswire.com/news/home/20230918666988/en/
    KRYLEX KURA-LOW adhesive technology available in formulations like KD7009.
  • Existing competitive adhesive systems typically require ‘high’ process temperatures or must be supplied in a two-component format which brings additional limitations to device assembly and reliability.

FTC to glue company: Stick to established Made in USA principles

Retrieved on: 
Wednesday, March 1, 2023

It’s “Made in USA” and the FTC just announced a settlement of its lawsuit against Chemence, Inc., for misleading Made in USA claims.

Key Points: 
  • It’s “Made in USA” and the FTC just announced a settlement of its lawsuit against Chemence, Inc., for misleading Made in USA claims.
  • The FTC also alleged that Chemence assisted others in deceiving consumers by distributing marketing materials to private-label sellers and third-party sites and storefronts that included misleading Made in USA claims.
  • The order also prohibits Chemence from providing others with the means to make deceptive Made in USA claims about its products.
  • Does your company make Made in USA claims on products or packaging, in ads, on your website, or in marketing materials?

Chemence Medical Receives FDA Approval for Exofin Fusion® Redesign

Retrieved on: 
Wednesday, April 7, 2021

ALPHARETTA, Ga., April 7, 2021 /PRNewswire/ -- Chemence Medical , a world leader in medical cyanoacrylate devices and products, announced the U.S. Federal Drug Administration's (FDA) 510(k) approval of the company's redesigned exofin fusion skin closure system.

Key Points: 
  • ALPHARETTA, Ga., April 7, 2021 /PRNewswire/ -- Chemence Medical , a world leader in medical cyanoacrylate devices and products, announced the U.S. Federal Drug Administration's (FDA) 510(k) approval of the company's redesigned exofin fusion skin closure system.
  • Chemence Medical made strategic updates to the product by reshaping the mesh strip and relocating the initiator after observing the common complaints found in the FDA MAUDE database.
  • Chemence Medical, Inc., headquartered in Atlanta, Georgia, has redefined the medical adhesives industry and become a world leader in the medical device arena since its beginning in 1994.
  • Chemence Medical manufactures and distributes adhesive-based medical devices used by many of the largest medical centers worldwide.

Chemence Opens New Research and Development Facility

Retrieved on: 
Thursday, March 25, 2021

ALPHARETTA, Ga., March 25, 2021 /PRNewswire/ --Chemence, a global company with specialized expertise in the field of polymerizable technology, announced the opening of the Chemence Center of Excellence, a state-of-the-art research and development facility in Alpharetta, Georgia.

Key Points: 
  • ALPHARETTA, Ga., March 25, 2021 /PRNewswire/ --Chemence, a global company with specialized expertise in the field of polymerizable technology, announced the opening of the Chemence Center of Excellence, a state-of-the-art research and development facility in Alpharetta, Georgia.
  • "To meet aggressive growth targets for our Medical and Performance Materials businesses, Chemence has been making significant investments into its technology team in recent years.
  • Chemence intends to continue growing into the facility, with a second phase planned that will house several corporate functions.
  • Other operating companies include a Medical facility in Georgia and an Industrial facility in the United Kingdom.

Reactives and Adhesives Market Worth Expected to Reach $19.8 Billion by 2023 | TBRC

Retrieved on: 
Tuesday, January 14, 2020

Read More On The Business Research Company's Reactives And Other Adhesives Market Report:

Key Points: 
  • Read More On The Business Research Company's Reactives And Other Adhesives Market Report:
    Major players in the global reactives and other adhesives market such as BASF SE, 3M, ADCO Global, Adhesives Research, American Biltrite, Avery Dennison, Chemence, Collano Adhesives, Dow Chemical, and H.B.
  • The reactives and other adhesives market is a segment of the global adhesives market.
  • The adhesives market is segmented by type into water-based adhesives, solvent-based adhesives, hot-melt-based adhesives, and reactive & others adhesives.
  • Among these segments, the water-based adhesives market accounted for the largest share in the global adhesives market.